Sweet's syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropenia

Journal of the American Academy of Dermatology

Volumn 35, Issue 4, 1996, Pages 629-631

  Richard, Marie Aleth ^a   Grob, Jean Jacques ^a   Laurans, Renaud ^a   Hesse, Sylvie ^a   Brunet, Philippe ^a   Stoppa, Anne Marie ^b   Bonerandi, Jean Jacques ^a   Berland, Yvon ^a   Maraninchi, Dominique ^b  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; CORTICOSTEROID; COTRIMOXAZOLE; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ARTICLE; BACTERIAL INFECTION; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; HUMAN; IMMUNOTHERAPY; KIDNEY FAILURE; LEUKOCYTE COUNT; NEUTROPENIA; PRIORITY JOURNAL; RECURRENT INFECTION; TOPICAL DRUG ADMINISTRATION;

EID: 0030453717     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90693-3     Document Type: Article

References (28)

1. Wakefield PE, James WD, Samlaska CP, et al. Colony-stimulating factors. J Am Acad Dermatol 1990;23:903-12.
2. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr Scand 1956;45(suppl 105):1-78.
3. Kostmann R. Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Paediatr Scand 1975;64:362-8.
4. Guba SC, Sartor CA, Hutchinson R, et al. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood 1994;83:1486-92.
5. Rappeport JM, Parkman R, Newburger P, et al. Correction of infantile agranulocytosis (Kostmann's syndrome) by allogenic bone transplantation. Am J Med 1980;68:605-9.
6. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574-80.
7. Weite K, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990;75:1056-63.
8. Weston B, Todd RF III, Axtell R, et al. Severe congenital neutropenia: clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. J Lab Clin Med 1991;117:282-90.
9. Payadas S, Sahin B, Seyrek E, et al. Sweet's syndrome associated with G-CSF. Br J Haematol 1993;85:191-2.
10. Johnson MML, Grimwood CRE. Leukocyte colony-stimulating factors: a review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994;130:77-81.
11. Weisbart RH, Gasson JC, Golde DW. Colony-stimulating factors and host defense. Ann Intern Med 1989;110:297-303.
12. Samlaska CP, Noyes DK. Localized cutaneous reactions to granulocyte colony-stimulating factor. Arch Dermatol 1993;129:645-6.
13. Mehregan DR, Fransway AF, Edmonson JH, et al. Cutaneous reactions to granulocyte-monocyte colony-stimulating factor. Arch Dermatol 1992;128:1055-9.
14. Horn TD, Burke PJ, Karp JE, et al. Intravenous administration of recombinant human granulocyte-macrophage colony stimulating factor causes a cutaneous eruption. Arch Dermatol 1991;127:49-52.
15. Farmer KL, Kurzrock R, Gutterman JU, et al. Necrotizing vasculitis at granulocyte-macrophage colony-stimulating factor injection sites. Arch Dermatol 1990;126:1243-4.
16. Negrin RS, Heuber DH, Nagler A, et al. Treatment of myelodysplastic syndromes with recombinant human granulocyte-colony stimulating factor. Ann Intern Med 1989; 110:976-84.
17. Kelly R, Marsden RA, Bevan D. Exacerbation of psoriasis with GM-CSF therapy. Br J Dermatol 1993;128:468-9.
18. Dreicer R, Schiller JH, Carbone PP. Granulocyte-macrophage colony-stimulating factor and vasculitis. Ann Intern Med 1989;111:91-2.
19. Jain KK. Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994;31: 213-5.
20. Wodzinski MA, Hampton KK, Reilly JT. Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia. Br J Haematol 1991;77:249-50.
21. Kluin-Nelemans JC, Hollander AAM, Fibbe WE, et al. Leukocytoclastic vasculitis during GM-CSF therapy. Br J Haematol 1989;73:419-20.
22. Ross HJ, Moy LA, Kaplan R, et al. Bullous pyoderma gangrenosum after granulocyte colony stimulating factor treatment. Cancer 1991;68:441-3.
23. Park JW, Mehrotra B, Barnett BO, et al. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med 1992;116:996-8.
24. Glaspy JA, Baldwin GC, Robertson PA, et al. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony stimulating factor. Ann Intern Med 1988;109:789-95.
25. Morioka N, Otsuka T, Nogita T, et al. Neutrophilic dermatosis with myelodysplastic syndrome: nuclear segmentation anomalies of neutrophils in the skin lesion and in peripheral blood. J Am Acad Dermatol 1990;23: 247-9.
26. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-59.
27. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31:535-56.
28. Piette WW, Trapp JF, O'Donnell MJ, et al. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol 1994;30:293-7.